LON:AZN - AstraZeneca Stock Price, News, & Analysis

AstraZeneca trades on the London Stock Exchange (LON) under the ticker symbol "AZN."

AstraZeneca declared a dividend on Thursday, July 26th. Stockholders of record on Thursday, August 9th will be given a dividend of GBX 68.40 per share on Monday, September 10th. This represents a dividend yield of 1.19%. The ex-dividend date of this dividend is Thursday, August 9th. The official announcement can be viewed at this link. View AstraZeneca's Dividend History.

23 equities research analysts have issued 1 year price targets for AstraZeneca's stock. Their predictions range from GBX 4,080 to GBX 6,600. On average, they expect AstraZeneca's stock price to reach GBX 5,665.33 in the next twelve months. This suggests that the stock has a possible downside of 4.5%. View Analyst Price Targets for AstraZeneca.

23 Wall Street analysts have issued "buy," "hold," and "sell" ratings for AstraZeneca in the last year. There are currently 2 sell ratings, 7 hold ratings and 14 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for AstraZeneca.

Some companies that are related to AstraZeneca include Sanofi (SAN), Bayer (BAYN), GlaxoSmithKline (GSK), BEXIMCO PHARMAC/S GDR REGS (BXP), OTSUKA HOLDINGS/ADR (OTSKY), Hutchison China MediTech (HCM), Dechra Pharmaceuticals (DPH), Mayne Pharma Group (MYX), Vectura Group (VEC), Eco Animal Health Group (EAH), Trilogy International Partners (TRL), Allergy Therapeutics (AGY), Sinclair Pharma (SPH), Pharmaxis (PXS) and NanoViricides (NNVC).

Press coverage about AZN stock has been trending somewhat positive on Sunday, Accern Sentiment reports. The research firm identifies negative and positive press coverage by analyzing more than 20 million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. AstraZeneca earned a coverage optimism score of 0.11 on Accern's scale. They also gave media headlines about the biopharmaceutical company an impact score of 45.39 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock's share price in the next few days. View Recent Headlines for AstraZeneca.

Shares of AZN and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

One share of AZN stock can currently be purchased for approximately GBX 5,930.

AstraZeneca has a market capitalization of £61.66 billion.

AstraZeneca's mailing address is 1 Francis Crick Avenue Cambridge Biomedical Campus, CAMBRIDGE, CB2 0AA, United Kingdom. The biopharmaceutical company can be reached via phone at +44-20-73045000.